Even & Pete: so are you saying that were we to get bought out that Kard Scientific would still continue to produce Menon’s Magic and that we would then have the opportunity to invest in Menon thru Kard? I’m not going to refuse a possible Pfizer windfall, should that occur within the next several months, but my preference would be the licensing or full pharma company options as I see those leading to longer-term investment and profit. It seems that we'd be disconnected from Menon's Magic were CTIX assimilated into the immensity of Pfizer or some other huge pharma. How could Kard play into things were Cellceutix to be bought out?